Therapeutics
Strategic expertise to help meet your critical milestones
Industry recognition. See more on the awards page.



You have a vision. We can help you get there.
From early-phase studies to late-stage trials, ICON’s therapeutic expertise helps you reach your key milestones at every stage of development.
Cross-therapeutics
Products
From early-phase development through post-market solutions, our expertise spans a wide range of product types across therapeutic areas.
Populations
We support clinical trial participants across all ages, conditions, and geographies—ensuring representative engagement that drives meaningful study outcomes.
Reach clinical trial participants faster with a patient-centric approach
At ICON, we help sponsors accelerate participant engagement and study success through a patient-first approach that blends journey insights, advocacy expertise, and advanced technology. Our integrated solutions—from concierge services to a proprietary digital platform and decentralised and hybrid trial models—reduce barriers, enhance engagement, and boost recruitment and retention from day one.
Explore our patient-centric innovations and expertise.

Drug development expertise at your fingertips
- Asset development consulting ICON offers global, robust integrated asset development consulting, covering all phases of drug development, to virtual companies, start-ups, biotechs, pharmaceutical, and medical device sponsors.
- Clinical Pharmacology Explore our deep expertise in early clinical development planning through proof-of-concept, including the design, execution, and analysis of clinical pharmacology studies with tailored pharmacodynamic biomarkers.
- Regulatory strategy From preclinical to post-approval, we accelerate your path to market with expert guidance through global regulatory complexities and evolving development challenges.
- Statistical advisory services Expert statistical solutions and experienced technical advice to design and support innovative clinical trials—tailored to your specific needs.
Asset development consulting
ICON offers global, robust integrated asset development consulting, covering all phases of drug development, to virtual companies, start-ups, biotechs, pharmaceutical, and medical device sponsors.
Clinical Pharmacology
Explore our deep expertise in early clinical development planning through proof-of-concept, including the design, execution, and analysis of clinical pharmacology studies with tailored pharmacodynamic biomarkers.
Regulatory strategy
From preclinical to post-approval, we accelerate your path to market with expert guidance through global regulatory complexities and evolving development challenges.
Statistical advisory services
Expert statistical solutions and experienced technical advice to design and support innovative clinical trials—tailored to your specific needs.
Case studies
We deliver innovative development strategies to maximise program value, speed patient access, and drive results—explore our case studies library to see how.
Fueling innovation
ICON fuels innovation in clinical development—accelerating trials with AI-enabled solutions, guiding biotech spin-offs, and supporting venture-backed teams from idea to execution. Achieve smarter, more agile trials with ICON’s cutting-edge technology.

Therapeutics insights
ICON therapeutic experts provide analysis including whitepapers, blogs and contributions to media and industry conversations relating to all aspects of clinical trials.